All Articles

Lysander Funds plans to convert its Canso Credit Income Fund to an ETF, tapping into a booming active fund market and seeking greater liquidity for investors.

Crinetics Pharmaceuticals aims to disrupt Brazil's acromegaly treatment with Palsonify, a once-daily pill challenging the standard of monthly injections.

As outdoor recreation booms and volunteer support wanes, a tech and auto partnership is scaling up efforts to restore threatened public land trails.

Out of home advertising isn't just surviving; it's booming. Discover why tech giants and emerging brands are pouring billions into real-world ads.

An Omaha couple's dedication to community and accessibility has earned them a top national award, highlighting a growing trend in home mobility solutions.

The pharma firm hit pause on a crucial reverse stock split needed to keep its Nasdaq listing, citing "timing considerations" and raising investor questions.

EnerSys will unveil its strategic framework and technology roadmap, outlining its plan to navigate the energy transition and capitalize on market growth.

The regional bank's dividend hike is backed by strong earnings and a favorable shift in capital rules, offering a bullish signal for investors.

Heritage Global promotes 20-year veteran Tom Ludwig to President of NLEX, signaling a focus on compliance and stability in the volatile loan sale market.

Vitesse Energy's founder CEO resigns immediately as the board names industry vet Jamie Benard his successor, signaling a major strategic shift for the firm.

The advanced optics maker announced a stock offering to fund operations as it navigates record revenue growth alongside plummeting profitability.

OPAL Fuels' Co-CEO will keynote at ACT Expo, highlighting how renewable natural gas offers fleets a path to cost savings and deep decarbonization.

With critical data due in 2026 and a leaner financial strategy, Zentalis is advancing its targeted therapy for a hard-to-treat ovarian cancer.

A multi-billion dollar tender for Argentina's main trade artery pits a US-backed group against a rival with alleged hidden ties to Chinese state firms.

After a record 2025 and claiming the #1 shaft spot at Club Champion, Newton Golf preps to show investors how physics is reshaping the golf market.

Apparel giant Oxford Industries posts a fiscal year loss after a major writedown, but sees a path to profit driven by a Tommy Bahama resurgence.

Securing a top financial award for the fourth year, Primrose Schools proves its low-risk, high-performance model helps franchisees thrive.

Keurig Dr Pepper's upcoming Q1 results are more than just numbers; they're the first look at a company on the brink of a massive transformation.

At a key investor conference, Renibus is pitching its two Phase 3 drugs, including one with a strategic pivot after a challenging trial result.

A promising oral therapy for a rare, aggressive lung cancer is now under review in Europe, offering a new option for patients with limited treatments.